Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by shawshank666on Jul 21, 2023 10:25am
139 Views
Post# 35551376

Surprising

SurprisingI am surprised to see the share price holding up with just 2 confirmed sales this year. My ex-co-workers loaded up at 17 cents and I did not. They got their average cost down to 30 cents and I did not.Too bad for me. To maintain a share price of 28/29 cents they will have to report a lot more sales for the year. There were no sales in the first quarter and the second quarter will probably see no sales again(to be released at the end of August) so right now I can see sales of approx. $140,000 for the third quarter(results to be release at the end of Nov.) that's if the German's pay the full amount for the VMS. I am not bashing the company. I am just stating the facts. They reported 2 big sales and now they have to keep the momentum going or else people will start to take some profits and the share price will go back below 20 cents. One would think that with 2 big hospitals buying the VMS there would be a stampede of other hospitals buying. Maybe there will be and it's too early still. I hope so.
<< Previous
Bullboard Posts
Next >>